Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Not Applicable

Completed

• Conditions: Alopecia Areata
• Interventions: Device: Narrow Band UVB; Drug: Calcipotriol; Diagnostic Test: vitamin D3 level

• Registration Number: NCT03847441
• Lead Sponsor: Aswan University Hospital

Brief Summary

Alopecia Areata is a common condition. This study investigated the efficacy of calcipotriol versus Narrow Band Ultraviolet B in treatment of Alopecia areata and their effects on serum vitamin D3 levels.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-10-01
• Primary Completion: 2018-12-31
• Study Completion: 2018-12-31
• Study First Submitted: 2019-02-18
• Study First Submitted QC: 2019-02-18
• Study First Posted: 2019-02-20
• Status Verified: 2019-03
• Last Update Submitted: 2019-03-29
• Last Update Posted: 2019-04-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Alopecia Areata of scalp

Exclusion Criteria

Other causes of alopecias including scarring alopecia, androgenic alopecia, telogen effluvium autoimmune diseases, pregnant and lactating females

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Group I	vitamin D3 level	-
Group II	Narrow Band UVB	-
Group II	vitamin D3 level	-
Group III	Narrow Band UVB	-
Group III	vitamin D3 level	-
Group IV	vitamin D3 level	-
Group I	Calcipotriol	-
Group III	Calcipotriol	-

Primary Outcome Measures

Name	Time	Method
Clinical improvement of Alopecia Areata After treatment As assessed by Severity of Alopecia tool (SALT) score	3 months	calculation of SALT score before and after treatment
Improvement of serum Vitamin D levels in (ng/ml) after treatment	3 months	measurement of serum vitamin D before and after treatment

Trial Locations

Locations (1)

Aswan University Hospital; 🇪🇬 Aswan, Egypt